Mouse Models for Studying Pain in Sickle Disease: Effects of Strain, Age, and Acuteness

Overview

Journal Br J Haematol

Specialty Hematology

Date 2011 Dec 17

PMID 22171826

Citations 65

Authors

David M Cain

Derek Vang

Donald A Simone

Robert P Hebbel

Kalpna Gupta

Affiliations

Soon will be listed here.

Abstract

The clinical management of severe pain associated with sickle cell disease (SCD) remains challenging. Development of an optimal therapy would be facilitated by use of murine model(s) with varying degrees of sickling and pain tests that are most sensitive to vaso-occlusion. We found that young (≤3 months old) NY1DD and S+S(Antilles) mice (having modest and moderate sickle phenotype, respectively) exhibited evidence of deep tissue/musculoskeletal pain. Deep tissue pain and cold sensitivity in S+S(Antilles) mice increased significantly with both age and incitement of hypoxia/reoxygenation (H/R). C57/BL6 mice (genetic background strain of NY1DD and S+S(Antilles) ) were hypersensitive to mechanical and heat stimuli, even without the sickle transgene. H/R treatment of HbSS-BERK mice with severe sickle phenotype resulted in significantly decreased withdrawal thresholds and enhanced mechanical, thermal and deep tissue hyperalgesia. Deep hyperalgesia incited by H/R in HbSS-BERK was ameliorated by CP 55940, a cannabinoid receptor agonist. Thus, assessment of deep tissue pain appears to be the most sensitive measure for studying pain mechanisms across mouse models of SCD, and HbSS-BERK mice may be the best model for vaso-occlusive and chronic pain of SCD.

Citing Articles

Heme-Oxygenase 1 Mediated Activation of Cyp3A11 Protects Against Non-Steroidal Pain Analgesics Induced Acute Liver Damage in Sickle Cell Disease Mice.

Vats R, Ungalara R, Dubey R, Sundd P, Pradhan-Sundd T Cells. 2025; 14(3).

PMID: 39936985 PMC: 11817884. DOI: 10.3390/cells14030194.

Mast cell extracellular trap formation underlies vascular and neural injury and hyperalgesia in sickle cell disease.

Argueta D, Tran H, Goel Y, Nguyen A, Nguyen J, Kiven S Life Sci Alliance. 2024; 7(11).

PMID: 39242155 PMC: 11381676. DOI: 10.26508/lsa.202402788.

CRISPR technology in human diseases.

Feng Q, Li Q, Zhou H, Wang Z, Lin C, Jiang Z MedComm (2020). 2024; 5(8):e672.

PMID: 39081515 PMC: 11286548. DOI: 10.1002/mco2.672.

Low-intensity transcranial focused ultrasound suppresses pain by modulating pain-processing brain circuits.

Kim M, Yu K, Yeh C, Fouda R, Argueta D, Kiven S Blood. 2024; 144(10):1101-1115.

PMID: 38976875 PMC: 11406192. DOI: 10.1182/blood.2023023718.

Sickle cell disease iPSC-derived sensory neurons exhibit increased excitability and sensitization to patient plasma.

Allison R, Welby E, Ehlers V, Burand A, Isaeva O, Nieves Torres D Blood. 2024; 143(20):2037-2052.

PMID: 38427938 PMC: 11143522. DOI: 10.1182/blood.2023022591.

References

Kaul D, Hebbel R . Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest. 2000; 106(3):411-20. PMC: 314325. DOI: 10.1172/JCI9225. View

Osarogiagbon U, Choong S, Belcher J, Vercellotti G, Paller M, Hebbel R . Reperfusion injury pathophysiology in sickle transgenic mice. Blood. 2000; 96(1):314-20. View

Kalambur V, Mahaseth H, Bischof J, Kielbik M, Welch T, Vilback A . Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy. Am J Hematol. 2004; 77(2):117-25. DOI: 10.1002/ajh.20143. View

Tuma R, Steffens S . Targeting the endocannabinod system to limit myocardial and cerebral ischemic and reperfusion injury. Curr Pharm Biotechnol. 2011; 13(1):46-58. DOI: 10.2174/138920112798868665. View

Ristoiu V, Shibasaki K, Uchida K, Zhou Y, Ton B, Flonta M . Hypoxia-induced sensitization of transient receptor potential vanilloid 1 involves activation of hypoxia-inducible factor-1 alpha and PKC. Pain. 2011; 152(4):936-945. DOI: 10.1016/j.pain.2011.02.024. View

Darbari D, Neely M, van den Anker J, Rana S . Increased clearance of morphine in sickle cell disease: implications for pain management. J Pain. 2011; 12(5):531-8. PMC: 3086992. DOI: 10.1016/j.jpain.2010.10.012. View

Dampier C, Ely B, Brodecki D, Oneal P . Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports. J Pain. 2003; 3(6):461-70. DOI: 10.1054/jpai.2002.128064. View

Dampier C, Setty B, Logan J, Ioli J, Dean R . Intravenous morphine pharmacokinetics in pediatric patients with sickle cell disease. J Pediatr. 1995; 126(3):461-7. DOI: 10.1016/s0022-3476(95)70472-8. View

Li Y, Hsieh S, Chien H, Zhang X, McArthur J, Griffin J . Sensory and motor denervation influence epidermal thickness in rat foot glabrous skin. Exp Neurol. 1997; 147(2):452-62. DOI: 10.1006/exnr.1997.6624. View

10.

Mogil J, Wilson S, Bon K, Lee S, Chung K, Raber P . Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception. Pain. 1999; 80(1-2):67-82. DOI: 10.1016/s0304-3959(98)00197-3. View

11.

Fabry M, Nagel R, Pachnis A, Suzuka S, Costantini F . High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences. Proc Natl Acad Sci U S A. 1992; 89(24):12150-4. PMC: 50716. DOI: 10.1073/pnas.89.24.12150. View

12.

Lunzer M, Yekkirala A, Hebbel R, Portoghese P . Naloxone acts as a potent analgesic in transgenic mouse models of sickle cell anemia. Proc Natl Acad Sci U S A. 2007; 104(14):6061-5. PMC: 1851616. DOI: 10.1073/pnas.0700295104. View

13.

Ballas S . Current issues in sickle cell pain and its management. Hematology Am Soc Hematol Educ Program. 2007; :97-105. DOI: 10.1182/asheducation-2007.1.97. View

14.

Paszty C, Brion C, Manci E, Witkowska H, Stevens M, Mohandas N . Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science. 1997; 278(5339):876-8. DOI: 10.1126/science.278.5339.876. View

15.

Kaul D, Liu X, Choong S, Belcher J, Vercellotti G, Hebbel R . Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice. Am J Physiol Heart Circ Physiol. 2004; 287(1):H293-301. DOI: 10.1152/ajpheart.01150.2003. View

16.

Solovey A, Kollander R, Shet A, Milbauer L, Choong S, Panoskaltsis-Mortari A . Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin. Blood. 2004; 104(3):840-6. DOI: 10.1182/blood-2003-10-3719. View

17.

Fuchs D, Birklein F, Reeh P, Sauer S . Sensitized peripheral nociception in experimental diabetes of the rat. Pain. 2010; 151(2):496-505. DOI: 10.1016/j.pain.2010.08.010. View

18.

Hillery C, Kerstein P, Vilceanu D, Barabas M, Retherford D, Brandow A . Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease. Blood. 2011; 118(12):3376-83. PMC: 3179403. DOI: 10.1182/blood-2010-12-327429. View

19.

Elikkottil J, Elikottil J, Gupta P, Gupta K . The analgesic potential of cannabinoids. J Opioid Manag. 2010; 5(6):341-57. PMC: 3728280. View

20.

Kollander R, Solovey A, Milbauer L, Abdulla F, Kelm Jr R, Hebbel R . Nuclear factor-kappa B (NFkappaB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease. Transl Res. 2010; 155(4):170-7. PMC: 2847430. DOI: 10.1016/j.trsl.2009.10.004. View